Dec 9 (Reuters) - Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
The site, the third new U.S. facility announced by Lilly, will make small-molecule synthetic and peptide medicines, including orforglipron, its first oral GLP-1 weight-loss drug anticipated to receive U.S. approval early next year.
Global pharmaceutical companies have been increasing U.S. investments after President Donald Trump urged the industry to make more medicines domestically rather than importing active ingredients or finished medicines.
Earlier this year, Lilly outlined plans to spend at least $27 billion on four new U.S. manufacturing sites to counter potential drug import duties. Lilly said another location will be announced in the coming weeks.
The company said the construction is slated to begin in 2026, creating about 3,000 construction jobs, with completion targeted for 2032. Lilly also plans 450 roles for engineers, scientists, operations personnel and lab technicians in the area.
CEO David Ricks said the investment advances the onshoring of active pharmaceutical ingredient production to strengthen supply resilience.
The company estimates every dollar invested could generate up to four dollars in local economic activity.
The site was chosen from more than 300 applications, aided by proximity to the HudsonAlpha Institute for Biotechnology, an established bioscience campus supporting workforce training and research, Lilly said.
Alabama Governor Kay Ivey called the project "the largest initial investment in our state's history."
Lilly said the plant will use machine learning, AI and digitally integrated monitoring systems, with automation embedded across operations.
The company also aims to work toward carbon neutrality at the site, said Edgardo Hernandez, Lilly's manufacturing operations head.
(Reporting by Puyaan Singh in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
US EPA will reassess safety of herbicide paraquat, says its chief - 2Cocoa Prices Sink on Favorable Crop Conditions in West Africa
- 3What we know about Jonathan Ross, the ICE agent who shot and killed Renee Nicole Good in Minneapolis
- 4Change Your Physical make-up: Compelling Activities for Muscle Building
- 5More parents refusing this shot that prevents serious bleeding at birth
- Damaged Shenzhou-20 spacecraft to return to Earth uncrewed for inspection
- Investigating Design and Individual Style: Track down Your Remarkable Look
- Compassion and Association: Building Significant Connections
- 4 buzzy new TV shows to watch — plus the return of 'The Comeback,' 'Jury Duty' and more
- Step by step instructions to Contrast Lab Precious stones and Normal Jewels
- Step by step instructions to Pick the Ideal Authorize Internet Advertising Degree Program
- Watch India launch advanced military satellite on rocket's 1st flight since May 2025 failure
- 10 times the sky amazed us in 2025
- Israel says it will keep control over part of southern Lebanon after war with Hezbollah ends
